| NF-κB, an Active Player in Human Cancers Y Xia, S Shen, IM Verma Cancer immunology research 2 (9), 823-830, 2014 | 1190 | 2014 |
| Andrographolide attenuates inflammation by inhibition of NF-κB activation through covalent modification of reduced cysteine 62 of p50 YF Xia, BQ Ye, YD Li, JG Wang, XJ He, X Lin, X Yao, D Ma, A Slungaard, ... The Journal of Immunology 173 (6), 4207-4217, 2004 | 476 | 2004 |
| IKK biology F Liu, Y Xia, AS Parker, IM Verma Immunological reviews 246 (1), 239-253, 2012 | 303 | 2012 |
| Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP Y Xia, RC Padre, TH De Mendoza, V Bottero, VB Tergaonkar, IM Verma Proceedings of the National Academy of Sciences 106 (8), 2629-2634, 2009 | 193 | 2009 |
| Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model Y Xia, N Yeddula, M Leblanc, E Ke, Y Zhang, E Oldfield, RJ Shaw, ... Nature cell biology 14 (3), 257-265, 2012 | 158 | 2012 |
| Targeting NF-κB in glioblastoma: A therapeutic approach D Friedmann-Morvinski, R Narasimamurthy, Y Xia, C Myskiw, Y Soda, ... Science Advances 2 (1), e1501292, 2016 | 144 | 2016 |
| NF-κB activation for constitutive expression of VCAM-1 and ICAM-1 on B lymphocytes and plasma cells YF Xia, LP Liu, CP Zhong, JG Geng Biochemical and biophysical research communications 289 (4), 851-856, 2001 | 113 | 2001 |
| A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin Y Xia, YL Liu, Y Xie, W Zhu, F Guerra, S Shen, N Yeddula, W Fischer, ... Science translational medicine 6 (263), 263ra161-263ra161, 2014 | 53 | 2014 |
| Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma N Yeddula, Y Xia, E Ke, J Beumer, IM Verma Proceedings of the National Academy of Sciences 112 (47), E6476-E6485, 2015 | 48 | 2015 |
| Targeting CREB pathway suppresses Small Cell lung Cancer Y Xia, C Zhan, M Feng, M Leblanc, E Ke, N Yeddula, IM Verma Molecular Cancer Research, molcanres. 0576.2017, 2018 | 46 | 2018 |
| Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells AM Kivelä, PI Mäkinen, HK Jyrkkänen, E Mella-Aho, Y Xia, E Kansanen, ... Atherosclerosis 213 (1), 122-128, 2010 | 45 | 2010 |
| Loss of redox factor 1 decreases NF-κB activity and increases susceptibility of endothelial cells to apoptosis Z Guan, D Basi, Q Li, A Mariash, YF Xia, JG Geng, E Kao, JL Hall Arteriosclerosis, thrombosis, and vascular biology 25 (1), 96-101, 2005 | 44 | 2005 |
| IFN regulatory factor-1 is required for the up-regulation of the CD40-NF-κB activator 1 axis during airway inflammation Z Zhao, Y Qian, D Wald, YF Xia, JG Geng, X Li The Journal of Immunology 170 (11), 5674-5680, 2003 | 29 | 2003 |
| Inflammatory tales of liver cancer A Hoffmann, Y Xia, IM Verma Cancer cell 11 (2), 99-101, 2007 | 25 | 2007 |
| Identification of alternatively spliced Act1 and implications for its roles in oncogenesis YF Xia, YD Li, X Li, JG Geng Biochemical and biophysical research communications 296 (2), 406-412, 2002 | 21 | 2002 |
| B lymphocytes and plasma cells express functional E-selectin by constitutive activation of NF-κB LP Liu, YF Xia, L Yang, JA DiDonato, PE DiCorleto, CP Zhong, JG Geng Biochemical and biophysical research communications 286 (2), 281-291, 2001 | 20 | 2001 |
| Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activation K Suzuki, SH Murphy, Y Xia, M Yokota, D Nakagomi, F Liu, IM Verma, ... PloS one 6 (9), e25412, 2011 | 18 | 2011 |
| Genetic and pharmacological interrogation of cancer vulnerability using a multiplexed cell line screening platform Y Xia, X Ji, IS Jang, C Surka, C Hsu, K Wang, M Rolfe, N Bence, G Lu Communications Biology 4 (1), 1-7, 2021 | 3 | 2021 |
| Tumor mouse models using lentiviral vectors T Marumoto, I Verma, Y Soda, Y Xia US Patent App. 12/074,854, 2008 | 3 | 2008 |
| Abstract A19: Role of NF-κB and gene targets of NF-κB in glioma cell plasticity D Friedmann-Morvinski, R Narasimamurthy, Y Xia, C Myskiw, Y Soda, ... Cancer Research 75 (23 Supplement), A19-A19, 2015 | | 2015 |
